about
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.Buprenorphine in Neonatal Abstinence Syndrome.Management of opioid use disorders: a national clinical practice guideline.Opioid antagonists with minimal sedation for opioid withdrawalOpioid substitution therapy: Legal challengesAssessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplaySex/gender reporting and analysis in Campbell and Cochrane systematic reviews: a cross-sectional methods study
P2860
Q44345917-6CB95747-B44C-4B7F-9AB6-E57EEABBA24AQ47122241-88C94946-44C3-4547-B2CF-54C5C362AF9DQ47653755-84B22B71-0203-4502-8009-2010E66B17F8Q52316126-8EE21C8F-31D1-4AA2-9CC9-A898F193544FQ56289303-57E4F73B-0E41-41C1-A875-C610FC9AD9F7Q58569714-3B565E39-7E29-4EFB-95D5-35A1EAC36366Q58721125-BBCF8D01-784F-4249-BCC9-544651A88B12Q58803203-D577379E-7363-4F45-9269-8256EAB53156
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Buprenorphine for managing opioid withdrawal.
@en
type
label
Buprenorphine for managing opioid withdrawal.
@en
prefLabel
Buprenorphine for managing opioid withdrawal.
@en
P2860
P1476
Buprenorphine for managing opioid withdrawal.
@en
P2093
Dalitso Mbewe
Jason M White
P2860
P304
P356
10.1002/14651858.CD002025.PUB5
P577
2017-02-21T00:00:00Z